CA2601700A1 - Phosphorylation des proteines suivant des voies controlees par les egfr - Google Patents
Phosphorylation des proteines suivant des voies controlees par les egfr Download PDFInfo
- Publication number
- CA2601700A1 CA2601700A1 CA002601700A CA2601700A CA2601700A1 CA 2601700 A1 CA2601700 A1 CA 2601700A1 CA 002601700 A CA002601700 A CA 002601700A CA 2601700 A CA2601700 A CA 2601700A CA 2601700 A1 CA2601700 A1 CA 2601700A1
- Authority
- CA
- Canada
- Prior art keywords
- rows
- protein
- corresponding column
- tyrosine
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000019491 signal transduction Effects 0.000 title claims abstract description 31
- 108060006698 EGF receptor Proteins 0.000 title claims description 110
- 230000009822 protein phosphorylation Effects 0.000 title description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 449
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 271
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 271
- 230000026731 phosphorylation Effects 0.000 claims abstract description 156
- 238000006366 phosphorylation reaction Methods 0.000 claims abstract description 156
- 238000000034 method Methods 0.000 claims abstract description 83
- 238000011002 quantification Methods 0.000 claims abstract description 73
- 102000005962 receptors Human genes 0.000 claims abstract description 49
- 108020003175 receptors Proteins 0.000 claims abstract description 49
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 48
- 102000027426 receptor tyrosine kinases Human genes 0.000 claims abstract description 28
- 108091008598 receptor tyrosine kinases Proteins 0.000 claims abstract description 28
- 102000001253 Protein Kinase Human genes 0.000 claims abstract description 26
- 108060006633 protein kinase Proteins 0.000 claims abstract description 26
- 102000002151 Microfilament Proteins Human genes 0.000 claims abstract description 17
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims abstract description 15
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims abstract description 15
- 239000003446 ligand Substances 0.000 claims abstract description 15
- 150000002632 lipids Chemical class 0.000 claims abstract description 14
- 230000004568 DNA-binding Effects 0.000 claims abstract description 13
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 claims abstract description 12
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 claims abstract description 12
- 101710204410 Scaffold protein Proteins 0.000 claims abstract description 12
- 108091005764 adaptor proteins Proteins 0.000 claims abstract description 12
- 102000018898 GTPase-Activating Proteins Human genes 0.000 claims abstract description 11
- 108010067218 Guanine Nucleotide Exchange Factors Proteins 0.000 claims abstract description 11
- 102000016285 Guanine Nucleotide Exchange Factors Human genes 0.000 claims abstract description 11
- 230000022983 regulation of cell cycle Effects 0.000 claims abstract description 11
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 claims abstract description 9
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 claims abstract description 9
- 239000000225 tumor suppressor protein Substances 0.000 claims abstract description 9
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 171
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 170
- 102000001301 EGF receptor Human genes 0.000 claims description 110
- 210000004027 cell Anatomy 0.000 claims description 70
- 102000034285 signal transducing proteins Human genes 0.000 claims description 49
- 108091006024 signal transducing proteins Proteins 0.000 claims description 49
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 claims description 43
- 108091000080 Phosphotransferase Proteins 0.000 claims description 24
- 102000020233 phosphotransferase Human genes 0.000 claims description 24
- 210000004408 hybridoma Anatomy 0.000 claims description 15
- 238000013518 transcription Methods 0.000 claims description 15
- 230000035897 transcription Effects 0.000 claims description 15
- 108010040897 Microfilament Proteins Proteins 0.000 claims description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 12
- 108010060434 Co-Repressor Proteins Proteins 0.000 claims description 9
- 102000008169 Co-Repressor Proteins Human genes 0.000 claims description 9
- 101710096438 DNA-binding protein Proteins 0.000 claims description 8
- 102100021238 Dynamin-2 Human genes 0.000 claims description 8
- 108010027920 GTPase-Activating Proteins Proteins 0.000 claims description 8
- 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 claims description 8
- 101710150114 Protein rep Proteins 0.000 claims description 8
- 101710152114 Replication protein Proteins 0.000 claims description 8
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 claims description 6
- 102000045108 human EGFR Human genes 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 2
- 108091008324 binding proteins Proteins 0.000 claims description 2
- 102000023732 binding proteins Human genes 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 93
- 238000001514 detection method Methods 0.000 abstract description 36
- 230000037361 pathway Effects 0.000 abstract description 6
- 102000040945 Transcription factor Human genes 0.000 abstract description 5
- 108091023040 Transcription factor Proteins 0.000 abstract description 5
- 102000005701 Calcium-Binding Proteins Human genes 0.000 abstract description 4
- 108010045403 Calcium-Binding Proteins Proteins 0.000 abstract description 4
- 102000010831 Cytoskeletal Proteins Human genes 0.000 abstract description 4
- 108010037414 Cytoskeletal Proteins Proteins 0.000 abstract description 4
- 108091006094 GTPase-accelerating proteins Proteins 0.000 abstract description 3
- 108091000387 actin binding proteins Proteins 0.000 abstract description 3
- 230000010076 replication Effects 0.000 abstract description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 abstract 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 abstract 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 203
- 235000002374 tyrosine Nutrition 0.000 description 103
- 230000000875 corresponding effect Effects 0.000 description 83
- 239000000427 antigen Substances 0.000 description 42
- 108091007433 antigens Proteins 0.000 description 42
- 102000036639 antigens Human genes 0.000 description 42
- 150000001413 amino acids Chemical group 0.000 description 34
- 235000001014 amino acid Nutrition 0.000 description 31
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 30
- 238000001228 spectrum Methods 0.000 description 29
- 150000002500 ions Chemical class 0.000 description 28
- 238000004885 tandem mass spectrometry Methods 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- 206010028980 Neoplasm Diseases 0.000 description 23
- 108010001441 Phosphopeptides Proteins 0.000 description 22
- -1 phospho Chemical class 0.000 description 22
- 241000282414 Homo sapiens Species 0.000 description 21
- 239000000523 sample Substances 0.000 description 21
- 238000004458 analytical method Methods 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 19
- 238000004949 mass spectrometry Methods 0.000 description 18
- 238000003786 synthesis reaction Methods 0.000 description 18
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 17
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 17
- 230000003436 cytoskeletal effect Effects 0.000 description 17
- 239000012634 fragment Substances 0.000 description 17
- 239000012472 biological sample Substances 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 230000027455 binding Effects 0.000 description 14
- 230000003053 immunization Effects 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 108010034219 Insulin Receptor Substrate Proteins Proteins 0.000 description 12
- 102000009433 Insulin Receptor Substrate Proteins Human genes 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 102000035195 Peptidases Human genes 0.000 description 12
- 108091005804 Peptidases Proteins 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000010561 standard procedure Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000001262 western blot Methods 0.000 description 12
- 238000003556 assay Methods 0.000 description 11
- 238000012216 screening Methods 0.000 description 11
- 239000004365 Protease Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 239000011324 bead Substances 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 239000013592 cell lysate Substances 0.000 description 9
- 238000011161 development Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 9
- 102100031983 Ephrin type-B receptor 4 Human genes 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 8
- 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 230000001413 cellular effect Effects 0.000 description 8
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 8
- 235000018417 cysteine Nutrition 0.000 description 8
- 238000002649 immunization Methods 0.000 description 8
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 7
- 108010017324 STAT3 Transcription Factor Proteins 0.000 description 7
- 102000004495 STAT3 Transcription Factor Human genes 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002955 isolation Methods 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 210000004989 spleen cell Anatomy 0.000 description 7
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 7
- 101800003838 Epidermal growth factor Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 101000573441 Homo sapiens Misshapen-like kinase 1 Proteins 0.000 description 6
- 101000626153 Homo sapiens Tensin-3 Proteins 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 6
- 102100026287 Misshapen-like kinase 1 Human genes 0.000 description 6
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 6
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 6
- 102100024548 Tensin-3 Human genes 0.000 description 6
- 240000006365 Vitis vinifera Species 0.000 description 6
- 239000012491 analyte Substances 0.000 description 6
- 210000004899 c-terminal region Anatomy 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940116977 epidermal growth factor Drugs 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- 230000002055 immunohistochemical effect Effects 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 108091005601 modified peptides Proteins 0.000 description 6
- 230000009257 reactivity Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000012588 trypsin Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000016362 Catenins Human genes 0.000 description 5
- 108010067316 Catenins Proteins 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 5
- 101000695043 Homo sapiens Serine/threonine-protein kinase BRSK1 Proteins 0.000 description 5
- 241000772415 Neovison vison Species 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000013467 fragmentation Methods 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 238000005040 ion trap Methods 0.000 description 5
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 230000011664 signaling Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 102100028623 Serine/threonine-protein kinase BRSK1 Human genes 0.000 description 4
- 101710142287 Talin-1 Proteins 0.000 description 4
- 102100036977 Talin-1 Human genes 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 230000009260 cross reactivity Effects 0.000 description 4
- 238000004163 cytometry Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000684 flow cytometry Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- YPJUNDFVDDCYIH-UHFFFAOYSA-N perfluorobutyric acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)F YPJUNDFVDDCYIH-UHFFFAOYSA-N 0.000 description 4
- 230000017854 proteolysis Effects 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 102000004148 Annexin A4 Human genes 0.000 description 3
- 108090000669 Annexin A4 Proteins 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 3
- 108091006109 GTPases Proteins 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 102000007298 Mucin-1 Human genes 0.000 description 3
- 108010008707 Mucin-1 Proteins 0.000 description 3
- 102000007079 Peptide Fragments Human genes 0.000 description 3
- 108010033276 Peptide Fragments Proteins 0.000 description 3
- 241000276498 Pollachius virens Species 0.000 description 3
- 230000004570 RNA-binding Effects 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000005754 cellular signaling Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000001360 collision-induced dissociation Methods 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000007783 downstream signaling Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 230000004576 lipid-binding Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000009456 molecular mechanism Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 102000000412 Annexin Human genes 0.000 description 2
- 108050008874 Annexin Proteins 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 102100028237 Breast cancer anti-estrogen resistance protein 1 Human genes 0.000 description 2
- 101100365988 Caenorhabditis elegans smc-5 gene Proteins 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102100027043 Discoidin, CUB and LCCL domain-containing protein 2 Human genes 0.000 description 2
- 102100031856 ERBB receptor feedback inhibitor 1 Human genes 0.000 description 2
- 101710156695 ERBB receptor feedback inhibitor 1 Proteins 0.000 description 2
- 108010055179 EphA4 Receptor Proteins 0.000 description 2
- 102100021616 Ephrin type-A receptor 4 Human genes 0.000 description 2
- 102100030083 Epsin-2 Human genes 0.000 description 2
- 101710065000 Epsin-2 Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 2
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 101000911787 Homo sapiens Discoidin, CUB and LCCL domain-containing protein 2 Proteins 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 101100182612 Homo sapiens LSR gene Proteins 0.000 description 2
- 101001096178 Homo sapiens Pleckstrin homology domain-containing family A member 5 Proteins 0.000 description 2
- 101001100101 Homo sapiens Retinoic acid-induced protein 3 Proteins 0.000 description 2
- 101001106406 Homo sapiens Rho GTPase-activating protein 1 Proteins 0.000 description 2
- 101000648012 Homo sapiens Signal transducing adapter molecule 1 Proteins 0.000 description 2
- 101000648038 Homo sapiens Signal transducing adapter molecule 2 Proteins 0.000 description 2
- 102000003839 Human Proteins Human genes 0.000 description 2
- 108090000144 Human Proteins Proteins 0.000 description 2
- 102100032010 Lipolysis-stimulated lipoprotein receptor Human genes 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- 108010006519 Molecular Chaperones Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000030412 Plakin Human genes 0.000 description 2
- 108091000120 Plakin Proteins 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 102100037866 Pleckstrin homology domain-containing family A member 5 Human genes 0.000 description 2
- 108700020471 RNA-Binding Proteins Proteins 0.000 description 2
- 102000044126 RNA-Binding Proteins Human genes 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102100038453 Retinoic acid-induced protein 3 Human genes 0.000 description 2
- 102100021433 Rho GTPase-activating protein 1 Human genes 0.000 description 2
- 101001092180 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RHO GTPase-activating protein RGD1 Proteins 0.000 description 2
- 102100037235 Sciellin Human genes 0.000 description 2
- 101710090926 Sciellin Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 102100025245 Signal transducing adapter molecule 1 Human genes 0.000 description 2
- 102100025265 Signal transducing adapter molecule 2 Human genes 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 102100031834 Unconventional myosin-VI Human genes 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000002788 anti-peptide Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- VGPYEHKOIGNJKV-UHFFFAOYSA-N asulam Chemical compound COC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VGPYEHKOIGNJKV-UHFFFAOYSA-N 0.000 description 2
- 230000004009 axon guidance Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003081 coactivator Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000001268 conjugating effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000003596 drug target Substances 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 229940022353 herceptin Drugs 0.000 description 2
- 230000000887 hydrating effect Effects 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 238000011532 immunohistochemical staining Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 108010049787 myosin VI Proteins 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 230000008823 permeabilization Effects 0.000 description 2
- 108091005981 phosphorylated proteins Proteins 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000009145 protein modification Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 239000012130 whole-cell lysate Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-O 1h-benzotriazol-1-ium Chemical compound C1=CC=C2[NH2+]N=NC2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-O 0.000 description 1
- FBTIVKFTXVEKJI-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound O.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F FBTIVKFTXVEKJI-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 102100022980 ADAMTS-like protein 4 Human genes 0.000 description 1
- 102100029824 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Human genes 0.000 description 1
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
- 102100036622 ATP-binding cassette sub-family A member 10 Human genes 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010063503 Actinin Proteins 0.000 description 1
- 102000010825 Actinin Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 102100036775 Afadin Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102100026451 Aldo-keto reductase family 1 member B10 Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108010033760 Amphiregulin Proteins 0.000 description 1
- 102100038778 Amphiregulin Human genes 0.000 description 1
- 101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 description 1
- 101100031730 Arabidopsis thaliana PUMP1 gene Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 102100023051 Band 4.1-like protein 4B Human genes 0.000 description 1
- 102400001242 Betacellulin Human genes 0.000 description 1
- 101800001382 Betacellulin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100028253 Breast cancer anti-estrogen resistance protein 3 Human genes 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102100032145 Carbohydrate sulfotransferase 10 Human genes 0.000 description 1
- 101710096630 Carbohydrate sulfotransferase 10 Proteins 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102100028906 Catenin delta-1 Human genes 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 102100038423 Claudin-3 Human genes 0.000 description 1
- 108090000599 Claudin-3 Proteins 0.000 description 1
- 102100038447 Claudin-4 Human genes 0.000 description 1
- 108090000601 Claudin-4 Proteins 0.000 description 1
- 108010037663 Cortactin Proteins 0.000 description 1
- 102000010958 Cortactin Human genes 0.000 description 1
- 102100024398 DCC-interacting protein 13-beta Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 101710160937 DNA replication protein Proteins 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 102100022263 Disks large homolog 3 Human genes 0.000 description 1
- 101150029707 ERBB2 gene Proteins 0.000 description 1
- 102100027117 Engulfment and cell motility protein 2 Human genes 0.000 description 1
- 108010055196 EphA2 Receptor Proteins 0.000 description 1
- 108010055182 EphA5 Receptor Proteins 0.000 description 1
- 108010055153 EphA7 Receptor Proteins 0.000 description 1
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 description 1
- 102100021605 Ephrin type-A receptor 5 Human genes 0.000 description 1
- 102100021606 Ephrin type-A receptor 7 Human genes 0.000 description 1
- 102100031982 Ephrin type-B receptor 3 Human genes 0.000 description 1
- 102400001329 Epiregulin Human genes 0.000 description 1
- 101800000155 Epiregulin Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 102100029987 Erbin Human genes 0.000 description 1
- 101700035123 Erbin Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 102100040612 Fermitin family homolog 3 Human genes 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 208000017891 HER2 positive breast carcinoma Diseases 0.000 description 1
- 102100027519 Hematopoietic SH2 domain-containing protein Human genes 0.000 description 1
- 108090001101 Hepsin Proteins 0.000 description 1
- 102000004989 Hepsin Human genes 0.000 description 1
- 102000006479 Heterogeneous-Nuclear Ribonucleoproteins Human genes 0.000 description 1
- 108010019372 Heterogeneous-Nuclear Ribonucleoproteins Proteins 0.000 description 1
- 101000975058 Homo sapiens ADAMTS-like protein 4 Proteins 0.000 description 1
- 101000794082 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Proteins 0.000 description 1
- 101000929654 Homo sapiens ATP-binding cassette sub-family A member 10 Proteins 0.000 description 1
- 101000718041 Homo sapiens Aldo-keto reductase family 1 member B10 Proteins 0.000 description 1
- 101000890401 Homo sapiens Amyloid beta precursor like protein 2 Proteins 0.000 description 1
- 101000924461 Homo sapiens Annexin A4 Proteins 0.000 description 1
- 101001049962 Homo sapiens Band 4.1-like protein 4B Proteins 0.000 description 1
- 101000935648 Homo sapiens Breast cancer anti-estrogen resistance protein 3 Proteins 0.000 description 1
- 101001053257 Homo sapiens DCC-interacting protein 13-beta Proteins 0.000 description 1
- 101000902100 Homo sapiens Disks large homolog 3 Proteins 0.000 description 1
- 101100118549 Homo sapiens EGFR gene Proteins 0.000 description 1
- 101001057855 Homo sapiens Engulfment and cell motility protein 2 Proteins 0.000 description 1
- 101001064458 Homo sapiens Ephrin type-B receptor 3 Proteins 0.000 description 1
- 101000749644 Homo sapiens Fermitin family homolog 3 Proteins 0.000 description 1
- 101001099051 Homo sapiens GPI inositol-deacylase Proteins 0.000 description 1
- 101001080225 Homo sapiens Hematopoietic SH2 domain-containing protein Proteins 0.000 description 1
- 101001077600 Homo sapiens Insulin receptor substrate 2 Proteins 0.000 description 1
- 101001139019 Homo sapiens Kin of IRRE-like protein 1 Proteins 0.000 description 1
- 101000942701 Homo sapiens Liprin-alpha-3 Proteins 0.000 description 1
- 101001039199 Homo sapiens Low-density lipoprotein receptor-related protein 6 Proteins 0.000 description 1
- 101001115426 Homo sapiens MAGUK p55 subfamily member 3 Proteins 0.000 description 1
- 101100130645 Homo sapiens MMP7 gene Proteins 0.000 description 1
- 101000955481 Homo sapiens Phosphatidylcholine translocator ABCB4 Proteins 0.000 description 1
- 101000591234 Homo sapiens Phosphatidylinositol phosphatase PTPRQ Proteins 0.000 description 1
- 101001096179 Homo sapiens Pleckstrin homology domain-containing family A member 6 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000591236 Homo sapiens Receptor-type tyrosine-protein phosphatase R Proteins 0.000 description 1
- 101000752245 Homo sapiens Rho guanine nucleotide exchange factor 5 Proteins 0.000 description 1
- 101000707228 Homo sapiens SH2 domain-containing protein 4A Proteins 0.000 description 1
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 description 1
- 101000835984 Homo sapiens SLIT and NTRK-like protein 6 Proteins 0.000 description 1
- 101000873645 Homo sapiens Secretory carrier-associated membrane protein 3 Proteins 0.000 description 1
- 101000632056 Homo sapiens Septin-9 Proteins 0.000 description 1
- 101000598025 Homo sapiens Talin-1 Proteins 0.000 description 1
- 101000649020 Homo sapiens Thyroid receptor-interacting protein 6 Proteins 0.000 description 1
- 101000634975 Homo sapiens Tripartite motif-containing protein 29 Proteins 0.000 description 1
- 101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 description 1
- 101000835634 Homo sapiens Tubulin-folding cofactor B Proteins 0.000 description 1
- 101000748161 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 34 Proteins 0.000 description 1
- 101001104110 Homo sapiens X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 Proteins 0.000 description 1
- 101000818633 Homo sapiens Zinc finger imprinted 3 Proteins 0.000 description 1
- 101000744882 Homo sapiens Zinc finger protein 185 Proteins 0.000 description 1
- 101000976622 Homo sapiens Zinc finger protein 42 homolog Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 1
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 1
- 102100023974 Keratin, type II cytoskeletal 7 Human genes 0.000 description 1
- 102100023972 Keratin, type II cytoskeletal 8 Human genes 0.000 description 1
- 108010066327 Keratin-18 Proteins 0.000 description 1
- 108010066302 Keratin-19 Proteins 0.000 description 1
- 108010070507 Keratin-7 Proteins 0.000 description 1
- 108010070511 Keratin-8 Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102100020687 Kin of IRRE-like protein 1 Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 1
- 102100035118 LIM and SH3 domain protein 1 Human genes 0.000 description 1
- 102100032892 Liprin-alpha-3 Human genes 0.000 description 1
- 102100040704 Low-density lipoprotein receptor-related protein 6 Human genes 0.000 description 1
- 102100030417 Matrilysin Human genes 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 101150033450 NUF2 gene Proteins 0.000 description 1
- 102000002356 Nectin Human genes 0.000 description 1
- 108060005251 Nectin Proteins 0.000 description 1
- 102400000058 Neuregulin-1 Human genes 0.000 description 1
- 108090000556 Neuregulin-1 Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000577979 Peromyscus spicilegus Species 0.000 description 1
- 102100039032 Phosphatidylcholine translocator ABCB4 Human genes 0.000 description 1
- 102100034105 Phosphatidylinositol phosphatase PTPRQ Human genes 0.000 description 1
- 102000004422 Phospholipase C gamma Human genes 0.000 description 1
- 108010056751 Phospholipase C gamma Proteins 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102100037869 Pleckstrin homology domain-containing family A member 6 Human genes 0.000 description 1
- 102100030477 Plectin Human genes 0.000 description 1
- 108010054050 Plectin Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 102100029292 Protein sprouty homolog 3 Human genes 0.000 description 1
- 101710082104 Protein sprouty homolog 3 Proteins 0.000 description 1
- 108010010469 Qa-SNARE Proteins Proteins 0.000 description 1
- 102100024939 RNA-binding motif protein, X chromosome Human genes 0.000 description 1
- 101710176041 RNA-binding motif protein, X chromosome Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 108091005682 Receptor kinases Proteins 0.000 description 1
- 102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 description 1
- 101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 102100021688 Rho guanine nucleotide exchange factor 5 Human genes 0.000 description 1
- 102100031777 SH2 domain-containing protein 4A Human genes 0.000 description 1
- 102100029198 SLAM family member 7 Human genes 0.000 description 1
- 108091006792 SLC20A2 Proteins 0.000 description 1
- 102100025504 SLIT and NTRK-like protein 6 Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 description 1
- 102100035895 Secretory carrier-associated membrane protein 3 Human genes 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 108050004875 Septin Proteins 0.000 description 1
- 102000015602 Septin Human genes 0.000 description 1
- 102100028024 Septin-9 Human genes 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102100032419 Sodium-dependent phosphate transporter 2 Human genes 0.000 description 1
- 102100027975 Syntaxin-4 Human genes 0.000 description 1
- 108010083809 Talin Proteins 0.000 description 1
- 102000006463 Talin Human genes 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102100028099 Thyroid receptor-interacting protein 6 Human genes 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 102100029519 Tripartite motif-containing protein 29 Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100036790 Tubulin beta-3 chain Human genes 0.000 description 1
- 102100026482 Tubulin-folding cofactor B Human genes 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 description 1
- 101710116241 Tyrosine-protein phosphatase non-receptor type 11 Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 102100040048 Ubiquitin carboxyl-terminal hydrolase 35 Human genes 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- 239000003875 Wang resin Substances 0.000 description 1
- 102100040089 X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 Human genes 0.000 description 1
- 102100021115 Zinc finger imprinted 3 Human genes 0.000 description 1
- 102100040032 Zinc finger protein 185 Human genes 0.000 description 1
- 102100023550 Zinc finger protein 42 homolog Human genes 0.000 description 1
- 108010023249 Zyxin Proteins 0.000 description 1
- 102100023895 Zyxin Human genes 0.000 description 1
- UACPLQANRQVKHE-UHFFFAOYSA-N [amino-[(4-hydroxyphenyl)methyl]phosphanyl]formic acid Chemical compound OC(=O)P(N)CC1=CC=C(O)C=C1 UACPLQANRQVKHE-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012082 adaptor molecule Substances 0.000 description 1
- 108010076838 afadin Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 230000035578 autophosphorylation Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 108700041286 delta Proteins 0.000 description 1
- 108010031971 delta catenin Proteins 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 229940080856 gleevec Drugs 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 102000056833 human BRSK1 Human genes 0.000 description 1
- 102000051957 human ERBB2 Human genes 0.000 description 1
- 102000047739 human IRS2 Human genes 0.000 description 1
- 102000054516 human TLN1 Human genes 0.000 description 1
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000013198 immunometric assay Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 108091006086 inhibitor proteins Proteins 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 102000019758 lipid binding proteins Human genes 0.000 description 1
- 108091016323 lipid binding proteins Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 235000020131 mattha Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 208000025440 neoplasm of neck Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 108091008104 nucleic acid aptamers Proteins 0.000 description 1
- 230000006548 oncogenic transformation Effects 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000001044 reversed-phase solid-phase extraction Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000007781 signaling event Effects 0.000 description 1
- 238000002553 single reaction monitoring Methods 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- CMZUMMUJMWNLFH-UHFFFAOYSA-N sodium metavanadate Chemical compound [Na+].[O-][V](=O)=O CMZUMMUJMWNLFH-UHFFFAOYSA-N 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- ZSZYCGVNBKEVPH-UHFFFAOYSA-N tyramine phosphate Chemical compound NCCC1=CC=C(OP(O)(O)=O)C=C1 ZSZYCGVNBKEVPH-UHFFFAOYSA-N 0.000 description 1
- 150000003668 tyrosines Chemical class 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2004/042940 WO2006068640A1 (fr) | 2004-12-21 | 2004-12-21 | Phosphorylation des protéines suivant des voies contrôlées par les egfr |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2601700A1 true CA2601700A1 (fr) | 2006-06-29 |
Family
ID=34959864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002601700A Abandoned CA2601700A1 (fr) | 2004-12-21 | 2004-12-21 | Phosphorylation des proteines suivant des voies controlees par les egfr |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1841882A1 (fr) |
| CA (1) | CA2601700A1 (fr) |
| WO (1) | WO2006068640A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9085622B2 (en) | 2010-09-03 | 2015-07-21 | Glaxosmithkline Intellectual Property Development Limited | Antigen binding proteins |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008008998A2 (fr) * | 2006-07-13 | 2008-01-17 | Cell Signaling Technology, Inc. | Réactifs pour la détection de phosphorylation de protéines dans les chemins de signalisation |
| WO2008009004A2 (fr) * | 2006-07-13 | 2008-01-17 | Cell Signaling Technology, Inc. | Réactifs pour la détection de la phosphorylation des protéines dans les voies de signalisation |
| EP2235536A4 (fr) | 2007-12-20 | 2011-05-04 | Lab Corp America Holdings | Procédés de diagnostic du her-2 |
| SG10201408392PA (en) | 2009-01-15 | 2015-01-29 | Lab Corp America Holdings | Methods of determining patient response by measurement of her-3 |
| JP6047503B2 (ja) * | 2010-12-29 | 2016-12-21 | エクスプレッション、パソロジー、インコーポレイテッドＥｘｐｒｅｓｓｉｏｎ Ｐａｔｈｏｌｏｇｙ， Ｉｎｃ． | Ｈｅｒ３タンパク質ＳＲＭ／ＭＲＭアッセイ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7198896B2 (en) * | 1998-09-04 | 2007-04-03 | Cell Signaling Technology, Inc. | Immunoaffinity isolation of modified peptides from complex mixtures |
| WO2003016861A2 (fr) * | 2001-08-14 | 2003-02-27 | President And Fellows Of Harvard College | Quantification absolue de proteines et de formes modifiees de proteine par spectrometrie de masse multistade |
-
2004
- 2004-12-21 WO PCT/US2004/042940 patent/WO2006068640A1/fr active Application Filing
- 2004-12-21 CA CA002601700A patent/CA2601700A1/fr not_active Abandoned
- 2004-12-21 EP EP04815061A patent/EP1841882A1/fr not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9085622B2 (en) | 2010-09-03 | 2015-07-21 | Glaxosmithkline Intellectual Property Development Limited | Antigen binding proteins |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006068640A1 (fr) | 2006-06-29 |
| EP1841882A1 (fr) | 2007-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1718760B1 (fr) | Phosphorylation des proteines dans les voies de signalisation c-src | |
| US7807789B2 (en) | Reagents for the detection of protein phosphorylation in EGFR-signaling pathways | |
| US7888480B2 (en) | Reagents for the detection of protein phosphorylation in leukemia signaling pathways | |
| EP2182057A1 (fr) | Anticorps contre tyrosine phosphorylée pour la détection de la phosphorylation de protéines dans des voies signalant un carcinome | |
| WO2007133702A2 (fr) | Réactifs pour la détection des chemins de signalisation de l'acétylation des protéines | |
| US20090298093A1 (en) | Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways | |
| US20090258442A1 (en) | Reagents for the detection of protein phosphorylation in carcinoma signaling pathways | |
| WO2008009000A2 (fr) | Réactifs pour la détection de phosphorylation de protéines dans les chemins de signalisation | |
| US20090061459A1 (en) | Reagents for the detection of protein phosphorylation in carcinoma signaling pathways | |
| US20090263832A1 (en) | Reagents for the Detection of Protein Phosphorylation in Leukemia Signaling Pathways | |
| US20110105732A1 (en) | Reagents for the Detection of Protein Phosphorylation in Carcinoma Signaling Pathways | |
| WO2007133689A2 (fr) | Réactifs pour la détection des chemins de signalisation de l'acétylation des protéines | |
| US7973134B2 (en) | Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways | |
| CA2601700A1 (fr) | Phosphorylation des proteines suivant des voies controlees par les egfr | |
| US20100173322A1 (en) | Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways | |
| US20090203034A1 (en) | Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathways | |
| EP1872134A2 (fr) | Réactifs de détection de phosphorylation de protéines dans la voie de signalisation de carcinome | |
| US7935790B2 (en) | Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways | |
| US7939636B2 (en) | Reagents for the detection of protein phosphorylation in c-Src signaling pathways | |
| WO2007027916A2 (fr) | Reactifs de detection de la phosphorylation proteinique dans la voie de signalisation de carcinome | |
| EP1929296A2 (fr) | Reactifs pour la detection de la phosphorylation proteique dans des voies de signalisation de lymphome anaplasique a grandes cellules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |